Hinge Health Inc. (NYSE:HNGE) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Hinge Health Inc. (NYSE:HNGE) have received a consensus recommendation of “Moderate Buy” from the nineteen brokerages that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, fifteen have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $75.80.

A number of analysts have weighed in on HNGE shares. Evercore reiterated an “outperform” rating and issued a $45.00 target price on shares of Hinge Health in a research note on Wednesday, April 8th. Barclays increased their target price on Hinge Health from $62.00 to $70.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. KeyCorp increased their target price on Hinge Health from $75.00 to $90.00 and gave the stock an “overweight” rating in a research note on Friday, June 12th. Royal Bank Of Canada raised their price target on Hinge Health from $65.00 to $75.00 and gave the company an “outperform” rating in a research note on Thursday, June 11th. Finally, Needham & Company LLC raised their price target on Hinge Health from $63.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, June 11th.

Insider Activity

In other news, major shareholder Insight Holdings Group, Llc sold 390,917 shares of the firm’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $71.15, for a total transaction of $27,813,744.55. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Antonio Perez sold 104,544 shares of the firm’s stock in a transaction on Wednesday, May 6th. The shares were sold at an average price of $55.09, for a total value of $5,759,328.96. Following the transaction, the chief executive officer owned 35,470 shares in the company, valued at approximately $1,954,042.30. This represents a 74.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,497,279 shares of company stock worth $97,492,856. Company insiders own 18.92% of the company’s stock.

Hedge Funds Weigh In On Hinge Health

Several institutional investors have recently made changes to their positions in HNGE. BIT Capital GmbH increased its stake in shares of Hinge Health by 79.3% during the fourth quarter. BIT Capital GmbH now owns 3,316,101 shares of the company’s stock valued at $154,033,000 after buying an additional 1,466,577 shares during the period. Vanguard Group Inc. increased its stake in shares of Hinge Health by 110.5% during the fourth quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company’s stock valued at $121,027,000 after buying an additional 1,367,693 shares during the period. Tiger Global Management LLC increased its stake in shares of Hinge Health by 227.1% during the fourth quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company’s stock valued at $83,877,000 after buying an additional 1,253,743 shares during the period. Marshall Wace LLP purchased a new position in shares of Hinge Health during the fourth quarter valued at $54,469,000. Finally, Millennium Management LLC boosted its position in Hinge Health by 225.0% during the fourth quarter. Millennium Management LLC now owns 1,479,642 shares of the company’s stock valued at $68,729,000 after purchasing an additional 1,024,317 shares in the last quarter.

Hinge Health Stock Up 6.1%

HNGE stock opened at $74.86 on Friday. The business’s fifty day simple moving average is $56.17 and its two-hundred day simple moving average is $47.33. Hinge Health has a twelve month low of $30.08 and a twelve month high of $75.17. The firm has a market cap of $5.79 billion and a price-to-earnings ratio of -6.07.

Hinge Health (NYSE:HNGE) last released its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The business had revenue of $182.31 million for the quarter. During the same quarter in the previous year, the business earned $1.30 EPS. The business’s revenue for the quarter was up 47.2% on a year-over-year basis. Research analysts expect that Hinge Health will post 1.33 EPS for the current year.

Key Headlines Impacting Hinge Health

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Hinge Health raised its Q2 2026 revenue guidance to $200 million-$202 million, above the Street’s $195 million estimate, and lifted full-year 2026 revenue guidance to $818 million-$824 million versus consensus of $801.6 million, signaling better-than-expected growth momentum.
• Positive Sentiment: Recent operating results remain strong, with the company’s last reported quarter showing 47.2% revenue growth and earnings that beat analyst expectations, helping support bullish sentiment around the stock.
• Neutral Sentiment: Wall Street remains broadly constructive on Hinge Health, with recent analyst price targets ranging from the high-$70s to $90 and a consensus rating of Moderate Buy, suggesting investors still see upside potential.
• Negative Sentiment: Insight Holdings Group, a major shareholder, sold multiple large blocks of HNGE shares in recent days, including transactions on June 22, June 23, and June 24. Although the sales were made under a pre-arranged Rule 10b5-1 plan, the volume of selling may pressure sentiment. SEC filing
• Negative Sentiment: President James Pursley also sold 33,000 shares, adding to the cluster of insider sales and raising questions about valuation after the stock’s recent run-up. SEC filing

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.